UPDATE 3-Biogen scraps Alzheimer drug trials, wiping $17 billion off its market value
March 21, 2019 at 10:15 AM EDT
* Analysts question Biogen's growth prospects (Adds context, details, background)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|